<bill session="106" type="h" number="2700" updated="2013-07-14T18:54:06-04:00">
  <state datetime="1999-08-04">REFERRED</state>
  <status>
    <introduced datetime="1999-08-04"/>
  </status>
  <introduced datetime="1999-08-04"/>
  <titles>
    <title as="introduced" type="short">HELP for Africa Act</title>
    <title as="introduced" type="short">Highly Essential Lifesaving Pharmaceuticals for Africa Act</title>
    <title as="introduced" type="official">To require that United States supported clinical research that is conducted in sub-Saharan African countries be conducted in accordance with the most protective ethical standards regarding the use of human research subjects, and to prohibit the revocation or revision of intellectual property or competition laws or policies of sub-Saharan African countries that are designed to promote access to pharmaceuticals or other medical technologies.</title>
  </titles>
  <sponsor id="400198"/>
  <cosponsors>
    <cosponsor id="400553" joined="1999-09-08"/>
    <cosponsor id="400050" joined="1999-09-08"/>
    <cosponsor id="400093" joined="2000-02-10"/>
    <cosponsor id="400227" joined="1999-09-08"/>
    <cosponsor id="400289" joined="1999-08-05"/>
    <cosponsor id="400306" joined="1999-09-08"/>
    <cosponsor id="400357" joined="1999-08-05"/>
    <cosponsor id="400360" joined="1999-09-08"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="1999-08-04">
      <text>Referred to the House Committee on International Relations.</text>
    </action>
    <action datetime="1999-09-01">
      <text>Referred to the Subcommittee on International Economic Policy and Trade.</text>
      <committee name="House Committee on International Relations"/>
    </action>
    <action datetime="1999-09-01">
      <text>Referred to the Subcommittee on Africa.</text>
      <committee name="House Committee on International Relations"/>
    </action>
  </actions>
  <committees>
    <committee code="HSFA" name="House International Relations" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSFA04" subcommittee="International Economic Policy and Trade" name="House International Relations"/>
    <committee activity="Referral" code="HSFA08" subcommittee="Africa" name="House International Relations"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="International affairs"/>
    <term name="Access to health care"/>
    <term name="Africa (Sub-Saharan)"/>
    <term name="American economic assistance"/>
    <term name="Antitrust law"/>
    <term name="Appropriations"/>
    <term name="Clinical trials"/>
    <term name="Commerce"/>
    <term name="Competition"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Economics and public finance"/>
    <term name="Federal aid to medical research"/>
    <term name="Federal receipts and expenditures"/>
    <term name="Foreign trade and international finance"/>
    <term name="Health"/>
    <term name="Human experimentation in medicine"/>
    <term name="Intellectual property"/>
    <term name="Medical ethics"/>
    <term name="Medical research"/>
    <term name="Medical technology"/>
    <term name="Patent agreements"/>
    <term name="Science, technology, communications"/>
    <term name="Trade agreements"/>
    <term name="Trade negotiations"/>
    <term name="Trademark agreements"/>
  </subjects>
  <amendments/>
  <summary>8/4/1999--Introduced.
Highly Essential Lifesaving Pharmaceuticals for Africa Act (HELP for Africa Act) - Prohibits the use of funds appropriated to any Federal department or agency: (1) for the conduct of clinical research in a sub-Saharan African country unless specified conditions are met; or (2) to seek, through negotiation or otherwise, the revocation or revision of any intellectual property or competition law or policy of a sub-Saharan African country that is designed to promote access to pharmaceuticals or other medical technologies, if such law or policy complies with the Agreement on Trade-Related Aspects of Intellectual Property Rights.</summary>
</bill>
